IMRT

Follow-up (median 54 months; range: 27-79 months)

3 locoregional relapses

MVA: R1 resection (p=0.03) ypN2 disease (p=0.04) UVA: adjuvant chemotherapy (p=0.04)

5-year: 97% LC 57% PFS 68% OS

MVA: R1 resection (p=0.03) ypN2 disease (p=0.04) UVA: adjuvant chemotherapy (p=0.04) ypT3-4 tumor (p=0.01) Dworak grade 0-2 (p=0.03)

De Ridder and Engels et al, Int J Radiat Oncol Biol Phys and Radiother Oncol 2008 - 2014

21